Thomas O’Hare
- Hematology top 0.1%
- Chronic Myeloid Leukemia Treatments 85
- Acute Myeloid Leukemia Research 13
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 70
- Myeloproliferative Neoplasms: Diagnosis and Treatment 13
- Rheumatology top 0.5%
- Eosinophilic Disorders and Syndromes 40
- Oncology top 5%
- Molecular Biology top 5%
-
- Acute Lymphoblastic Leukemia research 12
-
- Quinazolinone synthesis and applications 7
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Michael W. DeiningerBrian DrukerChristopher A. EideFrancis Y. LeeDenise K. WaltersEric P. StoffregenMichael C. HeinrichMatthew S. Zabriskie
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Thomas O’Hare
114 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Hematology 3.8k
- Genetics 2.9k
- Rheumatology 1.7k
- Oncology 966
- Molecular Biology 1.6k
Countries citing papers authored by Thomas O’Hare
This map shows the geographic impact of Thomas O’Hare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas O’Hare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas O’Hare more than expected).
Fields of papers citing papers by Thomas O’Hare
This network shows the impact of papers produced by Thomas O’Hare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas O’Hare. The network helps show where Thomas O’Hare may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas O’Hare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 28 | |
| 2 | 2018 | 5 | |
| 3 | 2018 | 42 | |
| 4 | 2017 | 0 | |
| 5 | 2017 | 1 | |
| 6 | 2016 | 4 | |
| 7 | 2015 | 128 | |
| 8 | 2015 | 14 | |
| 9 | 2013 | 23 | |
| 10 | 2013 | 17 | |
| 11 | 2012 | 100 | |
| 12 | 2012 | 227 | |
| 13 | Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemiasbreakdown → | 2012 | 527 |
| 14 | 2011 | 77 | |
| 15 | 2011 | 97 | |
| 16 | Activation switch pocket inhibitors target the T315I mutant of BCR-ABL | 2008 | 1 |
| 17 | 2007 | 17 | |
| 18 | In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutantsbreakdown → | 2005 | 812 |
| 19 | 1998 | 23 | |
| 20 | 1995 | 5 |
About Thomas O’Hare
Thomas O’Hare is a scholar working on Hematology, Genetics and Rheumatology, having authored 116 papers that have together received 5.7k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (85 papers), Chronic Lymphocytic Leukemia Research (70 papers), Eosinophilic Disorders and Syndromes (40 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers), Acute Myeloid Leukemia Research (13 papers), Acute Lymphoblastic Leukemia research (12 papers), Quinazolinone synthesis and applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Hematology (3.8k citations), Genetics (2.9k citations) and Rheumatology (1.7k citations). Thomas O’Hare has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Michael W. Deininger, Brian Druker, Christopher A. Eide, Francis Y. Lee, Denise K. Walters, Eric P. Stoffregen, Michael C. Heinrich, Matthew S. Zabriskie, Anna M. Eiring and Amie S. Corbin. Their work appears in journals such as Blood, Leukemia, Cancer Research, Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.